Clinical Trial Update: An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia [Phase 4]

View source ↗

Summary

Phase 4 open-label study assessing transitioning to lemborexant in Japanese adults with insomnia; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Lemborexant (lemborexant)

Snippet

Sponsor: Kurume University | Conditions: Insomnia | Phase 4 | Status: COMPLETED